These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4398120)

  • 21. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 23. [Some aspects of the physiological role of dopamine as a synaptic transmitter in basal ganglia and caudate nucleus].
    Kostowski W
    Acta Physiol Pol; 1972; 23():97-114. PubMed ID: 4338739
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the regional biosynthesis and metabolism of catecholamines in the central nervous system of the monkey.
    Goldstein M; Anagnoste B; Owen WS; Battista AF
    Experientia; 1967 Feb; 23(2):98-9. PubMed ID: 4382238
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and release of noradrenaline and dopamine from discrete regiions of monkey brain.
    Roth RH; Allikmets L; Delgado JM
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):273-82. PubMed ID: 4997253
    [No Abstract]   [Full Text] [Related]  

  • 27. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Apr; 145(1):69-83. PubMed ID: 638784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

  • 30. Release of dopamine in vivo from cat substantia nigra.
    Nieoullon A; Cheramy A; Glowinski J
    Nature; 1977 Mar; 266(5600):375-7. PubMed ID: 859606
    [No Abstract]   [Full Text] [Related]  

  • 31. Simultaneous recording of substantia nigra neurons and voltammetric release of dopamine in the caudate of behaving cats.
    Trulson ME
    Brain Res Bull; 1985 Aug; 15(2):221-3. PubMed ID: 4041929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous determination of 3H-labelled 3,4-dihydroxyphenethylamine (dopamine) synthesis and release in the cat caudate nucleus in vivo.
    Chéramy A; Glowinski J; Besson MJ; Gauchy C
    Biochem Soc Trans; 1976; 4(1):20-2. PubMed ID: 1001628
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo measurement of [3H]GABA release: an approach to the study of the regulation of GABA-containing neurons in the basal ganglia and associated structures in the cat and the rat.
    Besson MJ; Kemel ML; Gauchy C; Girault JA; Spampinato U; Lantin N; Desban M; Glowinski J
    Ann N Y Acad Sci; 1986; 473():475-88. PubMed ID: 3541740
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    Brain Res; 1974 Mar; 68(2):253-60. PubMed ID: 4826898
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus.
    Greenfield S; Cheramy A; Leviel V; Glowinski J
    Nature; 1980 Mar; 284(5754):355-7. PubMed ID: 7360271
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".
    Roth RH; Suhr Y
    Biochem Pharmacol; 1970 Dec; 19(12):3001-12. PubMed ID: 5513037
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1978 Jan; 47(2):141-7. PubMed ID: 620681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat.
    Chéramy A; Nieoullon A; Glowinski J
    J Pharmacol Exp Ther; 1977 Nov; 203(2):283-93. PubMed ID: 909063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.